Filing Details

Accession Number:
0001567619-22-021651
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-15 16:33:15
Reporting Period:
2022-12-13
Accepted Time:
2022-12-15 16:33:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626971 Corvus Pharmaceuticals Inc. CRVS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
939012 Leiv Lea C/O Corvus Pharmaceuticals, Inc.
863 Mitten Road, Suite 102
Burlingame CA 94010
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-13 30,000 $0.74 129,238 No 4 P Indirect By IRA
Common Stock Acquisiton 2022-12-14 4,000 $0.84 133,238 No 4 P Indirect By IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By IRA
No 4 P Indirect By IRA
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 149,206 Indirect By Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7255 to $0.7806, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. These shares are held by Leiv Lea IRA Contributory.
  3. These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the "Karlson Lea Trust"). Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust.